The federal contract IDV awarded to Werfen USA LLC by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 is for the lease and supply of Werfen GEM 7000 analyzers over a 5-year period. The $79,985.88 delivery order contract does not have a set-aside designation. Werfen, a manufacturer of in vitro diagnostic equipment, has previously delivered similar laboratory analyzers, reagents, and associated materials to other VA regional networks, the Defense Health...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs Veterans Integrated Service Network 6 (VA VISN 6) to Werfen USA LLC, a for-profit manufacturer of in vitro diagnostic equipment, reagents, and services. The $210,785.85 single-award contract provides the VA VISN 6 healthcare network access to specialized blood analyzers, reagents, and associated consumables to support critical transfusion and compatibility testing services within VA medical...
This Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to the prime contractor Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The contract is for the provision of clinical laboratory coagulation instrumentation, including analyzers, reagents, controls, and calibrators, to support the VA's healthcare services for veterans. The contract has a...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) awarded a Blanket Purchase Agreement (BPA) to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The $225,000 BPA, awarded on April 1, 2024 with an ultimate completion date of March 31, 2029, is to provide blood bank reagents in support of the VA's blood banking operations and healthcare services. The VA has also awarded two task orders under this BPA to...
This federal contract award to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services, provides the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 with specialized autoimmune testing IFA_EIA (NTX) products and cost-per-test services. The $184,416.77 firm fixed price delivery order, awarded on September 19, 2024, has a period of performance ending on September 18, 2025. Additionally, a separate $156,516.26 firm fixed price delivery...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the U.S. Department of Veterans Affairs (VA) Integrated Service Network 17 (VISN 17) to Werfen USA LLC, a manufacturer of in vitro diagnostic (IVD) medical equipment. The BPA, valued at up to $2,000,000, is for the provision of coagulation cost-per-reportable-result orders and associated testing products and services to support the medical diagnostic needs of VA facilities in North Texas. The task orders issued under...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a blanket purchase agreement to Werfen USA LLC for coagulation testing instruments and supplies. The single award IDV has a potential value of $3.5 million and establishes Werfen as a prime contractor through September 2026. Werfen will provide medical devices, reagents, controls, and associated materials to support blood coagulation and clinical pathology programs within VA...
This Indefinite Delivery Contract was awarded by the U.S. Department of Veterans Affairs (VA) to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $1,482,998.15 contract is for the provision of hematology products and services, including coagulation analyzers, reagents, and related supplies, to support healthcare programs within the VA's Veterans Integrated Service Network 8. This single-award contract has a period of performance through March 31, 2029....
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6) awarded a Blanket Purchase Agreement (BPA) contract to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The contract, which does not have a set-aside designation, is for the provision of GEM PREMIER 5000 ANALYZER WITH TEST CARTRIDGES to support blood coagulation, hematology, clinical chemistry, and microbiology testing programs at VA hospitals and clinics...
This indefinite delivery contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 (VISN 15) to Werfen USA LLC, a for-profit limited liability company based in Bedford, Massachusetts, is for the delivery of coagulation analyzers and reagents used for medical diagnostic testing in clinical laboratory settings serving veterans and other federal healthcare populations. The contract, valued at $612,954.71, is a firm fixed-price delivery order issued...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 (VISN 22) awarded a single award indefinite delivery contract to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic (IVD) equipment, reagents, and services. The $898,092.65 contract provides IVD products to support blood coagulation, hematology, clinical chemistry, and microbiology testing programs serving veterans at VA medical facilities within VISN 22. The contract has a period of performance from September 1, 2021 to August 31, 2026 and does not utilize any set-aside designations.
Under the IDV, the VA has issued multiple firm-fixed price delivery orders to Werfen USA and Immucor Inc., another IVD manufacturer, to supply specialized medical devices, consumables, and associated maintenance services. The delivery orders, valued between $10,000 to $116,000, facilitate the recurring procurement of essential diagnostic testing supplies, blood analyzers, and related equipment to enable the VA's provision of quality healthcare services to veterans across the VISN 22 region encompassing facilities in Arizona, California, and New Mexico.